Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.

Title:	Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.
Author(s):	Desar, I.M.E. (321523962) Bovenschen, H.J. (298209055) Timmer-Bonte, J.N.H. (306041189) Cantarini, M.V. Graaf, W.T.A. van der (113100892) Rossum, M.M. van (242448356) Herpen, C.M.L. van (270423702)
Publication year:	2010
Document type:	Article / Letter to editor
Journal:	Acta Oncologica
ISSN:	0284-186X
Volume:	vol. 49
Issue:	iss. 1
Start page:	p. 110
End page:	p. 113
Subject:	N4i 1: Pathogenesis and modulation of inflammation ONCOL 3: Translational research
Organization:	Medical Oncology Dermatology Pulmonary Diseases UMCN Extern
Appears in Collections:	Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/88064